Nobody warned me that the same hormonal shift causing hot flashes could also be quietly setting the stage for a gallbladder attack. When the pain hit — sharp, sudden, under the right ribs — gallstones were the last thing on my radar. If this article had existed then, I would have connected the dots much sooner and made different choices about how I was eating and what form of HRT I considered.
Learn more about Rose →Estrogen stimulates the liver to secrete more cholesterol into bile while simultaneously reducing the bile salts that keep that cholesterol dissolved. When bile becomes supersaturated with cholesterol — a state called lithogenic bile — crystals form and eventually cluster into gallstones. This mechanism is why gallstone prevalence rises sharply in women during the reproductive years and accelerates again around perimenopause when estrogen levels become erratic.
The gallbladder needs adequate hormonal signaling to contract fully and expel bile into the digestive tract after a meal — a process called gallbladder motility. As estrogen falls during menopause, gallbladder emptying slows and becomes incomplete, allowing bile to sit and concentrate for longer periods. Stagnant, concentrated bile dramatically increases the likelihood that cholesterol crystals will form and nucleate into stones.
Multiple large observational studies, including analyses from the Women's Health Initiative and the Million Women Study, show that oral estrogen roughly doubles the risk of gallbladder disease compared to women not using HRT. The key distinction is the route of delivery: oral estrogen passes through the liver first — the so-called first-pass effect — where it directly amplifies cholesterol secretion into bile. Transdermal estrogen (patches, gels, sprays) largely bypasses the liver and has been shown in several studies to carry a significantly lower, and in some analyses near-neutral, gallbladder risk.
The hormonal shift of menopause promotes redistribution of body fat toward the abdomen, and higher body weight is one of the strongest independent risk factors for gallstones. Excess adipose tissue increases the liver's cholesterol output and raises insulin levels, both of which tip bile composition toward lithogenicity. Women who gain significant abdominal weight during the menopause transition are therefore hit by two converging risk pathways simultaneously.
When fat is mobilized quickly, the liver secretes a surge of cholesterol into bile, and a severely restricted diet also reduces the fat intake needed to stimulate regular gallbladder contractions. Studies show that losing more than 1–1.5 kg per week substantially raises acute gallstone risk, with some research putting stone formation rates as high as 30% during very low-calorie diets. For menopausal women already carrying elevated baseline risk, crash dieting is genuinely hazardous rather than merely inadvisable.
Perimenopause accelerates the development of insulin resistance in many women, and elevated insulin independently increases hepatic cholesterol synthesis and secretion into bile. High circulating insulin also impairs gallbladder smooth muscle function, further compromising motility. This means women who develop metabolic changes during the menopause transition are facing gallbladder risk from multiple directions at once, not just from hormonal fluctuation alone.
Dietary fat is the primary signal that prompts the gallbladder to contract and empty; without it, bile pools and stagnates. Women who adopt very low-fat diets — often in response to menopausal weight gain — may inadvertently reduce the gallbladder stimulation needed to prevent bile from becoming dangerously concentrated. Research consistently shows that including moderate amounts of healthy fat at each meal supports gallbladder motility and lowers stone risk compared to fat-restricted eating patterns.
Multiple large prospective cohort studies have found that regular coffee consumption — roughly two to three cups per day — is associated with a meaningfully lower risk of symptomatic gallstones in women. The proposed mechanisms include caffeine stimulating gallbladder contractions, reducing cholesterol saturation in bile, and modulating bile acid composition. This is one of the more consistent dietary associations in gallstone epidemiology and applies to both caffeinated and, to a lesser extent, decaffeinated coffee.
Ursodeoxycholic acid (UDCA) is a naturally occurring bile acid available as a prescription medication that reduces cholesterol saturation in bile, promotes gallbladder emptying, and can slowly dissolve small cholesterol-based gallstones in some patients. For women who have risk factors but wish to continue oral HRT, or who are losing weight intentionally, UDCA is the only pharmacological option with a genuine evidence base for gallstone prevention. This is a conversation worth having explicitly with a doctor — not a supplement decision to make independently.
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.